{"id":221313,"date":"2024-04-06T21:32:40","date_gmt":"2024-04-06T21:32:40","guid":{"rendered":"https:\/\/michigandigitalnews.com\/index.php\/2024\/04\/06\/wegovy-eases-heart-failure-symptoms-for-patients-with-diabetes-study\/"},"modified":"2025-06-25T17:19:09","modified_gmt":"2025-06-25T17:19:09","slug":"wegovy-eases-heart-failure-symptoms-for-patients-with-diabetes-study","status":"publish","type":"post","link":"https:\/\/michigandigitalnews.com\/index.php\/2024\/04\/06\/wegovy-eases-heart-failure-symptoms-for-patients-with-diabetes-study\/","title":{"rendered":"Wegovy eases heart failure symptoms for patients with diabetes: Study"},"content":{"rendered":"

[ad_1]
\n
<\/p>\n

\n

Wegovy, the blockbuster weight-loss medication from\u00a0Novo Nordisk A\/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use of the drug to treat health conditions linked to obesity.<\/p>\n

\n

Patients who took Wegovy reported less fatigue, less leg swelling, were less short of breath and were able to walk farther in six minutes than those who got a placebo, researchers\u00a0reported<\/a>\u00a0on Saturday in the New England Journal of Medicine. The Wegovy patients also reported fewer serious medical problems.<\/p>\n

The study is the latest in a series of large trials Novo is running to prove that Wegovy can help people with a range of conditions from knee arthritis to\u00a0cardiovascular<\/a>\u00a0disease. The Danish drugmaker is using the results to build its case that cost-conscious insurers should pay for the medicine, which has a list price of about $1,350 per month in the US.<\/p>\n

The heart failure study published Saturday is part of a pair of trials that looked at heart failure with preserved ejection fraction, a\u00a0condition<\/a>\u00a0that occurs when the lower chamber of the heart pumps less blood than the body needs. It affects about 3 million people in the US and as many as 32 million people around the world, with an annual mortality rate of about 15%, according to a\u00a0review<\/a>\u00a0published last year in the medical journal JAMA.<\/p>\n

Novo disclosed initial results of the heart failure study when it reported fourth-quarter earnings in January. The study in people with diabetes follows on from a similar trial\u00a0published<\/a>\u00a0last year of heart failure patients who had obesity, but not diabetes. The company filed the results of both trials with US and European regulators in January.<\/p>\n

\u2014 With assistance from Madison Muller<\/em><\/p>\n<\/div>\n

Subscribe to Well Adjusted, our newsletter full of simple strategies to work smarter and live better, from the Fortune Well team. Sign up<\/a> for free today.<\/div>\n<\/div>\n

[ad_2]
\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

[ad_1] Wegovy, the blockbuster weight-loss medication from\u00a0Novo Nordisk A\/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use<\/p>\n","protected":false},"author":1,"featured_media":221314,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[149],"tags":[],"_links":{"self":[{"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/posts\/221313"}],"collection":[{"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/comments?post=221313"}],"version-history":[{"count":1,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/posts\/221313\/revisions"}],"predecessor-version":[{"id":330108,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/posts\/221313\/revisions\/330108"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/media\/221314"}],"wp:attachment":[{"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/media?parent=221313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/categories?post=221313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/tags?post=221313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}